Recursion Pharmaceuticals, Inc. (RXRX) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Recursion Pharmaceuticals, Inc. (RXRX): 1Y return -19.3%, Sharpe ratio 0.06, volatility 72.1%, max drawdown -58.2%. A Stock in the Equity asset class. Compare RXRX with other assets and invest through your own broker with pfolio.
Recursion Pharmaceuticals, Inc. (RXRX) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
RXRX Performance
- MTD
- Return: 3.8%, Sharpe: 1.01, Volatility: 60.9%, Max Drawdown: -19.0%
- YTD
- Return: -12.2%, Sharpe: -0.21, Volatility: 60.9%, Max Drawdown: -42.7%
- 1Y
- Return: -19.3%, Sharpe: 0.06, Volatility: 72.1%, Max Drawdown: -58.2%
- 5Y
- Return: -86.4%, Sharpe: 0.01, Volatility: 91.7%, Max Drawdown: -93.1%
Frequently Asked Questions
- What is Recursion Pharmaceuticals, Inc. (RXRX)?
- Recursion Pharmaceuticals, Inc. (RXRX) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does RXRX compare to other assets?
- You can compare RXRX with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in RXRX through pfolio?
- pfolio helps you build diversified portfolios that may include RXRX. You invest through your own broker — pfolio provides the analytics.